# US 2020/0370060 A1 · Methods and platforms for sustainable high yield terpenoid production

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0370060 A1
- Document ID: US20200370060A1
- Status: Published application
- Kind: A1
- Application number: 16/423,017
- Filed: 2019-05-26
- Published: 2020-11-26
- Earliest claimed: 2019-05-26
- Assignees: Purdue Research Foundation
- Applicants: Purdue Research Foundation; Salk Institute for Biological Studies
- Inventors: Natalia Doudareva; Joseph Noel; Laura Henry; Suzanne T. Thomas
- Web page: https://patentgrep.com/patent/US20200370060A1

## CPC

- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 15/8216: {Methods for controlling, regulating or enhancing expression of transgenes in plant cells}
- A01H 6/20: Brassicaceae, e.g. canola, broccoli or rucola
- C12N 9/1229: {Phosphotransferases with a phosphate group as acceptor (2.7.4)}
- C12N 15/8243: {involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01H: NEW PLANTS OR {NON-TRANSGENIC} PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES

## Abstract

Transgenic plants and methods for terpenoid production leveraging such transgenic plants are provided. Such transgenic plants may comprise a first heterologous nucleic acid encoding a polypeptide having 3-hydroxy-3-methylglutarylCoA reductase activity and a second heterologous nucleic acid encoding a polypeptide that introduces de novo formation of isopentenyl phosphate in the plant. Such de novo IP production may be achieved through the overexpression of phosphomevalonate decarboxylase in conjunction with 3-hydroxy-3-methylglutarylCoA reductase, which can result in up to a 130-fold increase of terpenoid production as compared to a wild-type plant.

## Claims

### Claim 1

A transgenic plant comprising a first heterologous nucleic acid encoding a polypeptide having 3-hydroxy-3-methylglutarylCoA reductase (HMGR) activity and a second heterologous nucleic acid encoding a polypeptide that introduces de novo formation of isopentenyl phosphate (IP) in the transgenic plant or a polypeptide having phosphomevalonate kinase (PMK) activity, wherein the polypeptide having HMGR activity and the polypeptide encoded by the second heterologous nucleic acid are overexpressed in the transgenic plant as compared to a corresponding wild-type plant.

### Claim 2 (depends on 1)

The transgenic plant of claim 1, wherein the first heterologous nucleic acid encoding a polypeptide having HMGR activity is from Arabidopsis.

### Claim 3 (depends on 1)

The transgenic plant of claim 1, wherein the polypeptide encoded by the second heterologous nucleic acid introduces de novo formation of IP in the transgenic plant and has phosphomevalonate decarboxylase (MPD) activity.

### Claim 4 (depends on 3)

The transgenic plant of claim 3, wherein the second heterologous nucleic acid comprises a bacterial gene.

### Claim 5 (depends on 3)

The transgenic plant of claim 3, wherein the transgenic plant produces an increased amount of metabolically available IP relative to an amount of metabolically available IP produced in a corresponding wild-type plant.

### Claim 6 (depends on 1)

The transgenic plant of claim 1, further comprising a third heterologous nucleic acid comprising a sequence encoding a synthase for catalyzing the formation of an exogenous terpenoid product of interest, wherein the transgenic plant expresses at least a portion of the exogenous terpenoid product of interest.

### Claim 7 (depends on 1)

The transgenic plant of claim 1, wherein polypeptide encoded by the second heterologous nucleic acid has PMK activity and monoterpene and sesquiterpene production of the transgenic plant is at or near 20-fold greater and at or near 130-fold greater, respectively, than monoterpene and sesquiterpene production in the corresponding wild-type plant.

### Claim 8 (depends on 1)

The transgenic plant of claim 1, wherein one or both of the first and second heterologous nucleic acids is operably linked to a regulatory element for directing expression of the first and second heterologous nucleic acids.

### Claim 9 (depends on 8)

The transgenic plant of claim 8, wherein the regulatory element comprises a tissue-specific promoter for directing expression of the first or second heterologous nucleic acid in the plant cells of a leaf, root, flower, developing ovule or seed of the transgenic plant.

### Claim 10 (depends on 1)

The transgenic plant of claim 1, wherein the transgenic plant is selected from the group consisting of: tobacco, rice, flax, wheat, barley, rye, corn, potato, pea, lettuce, cabbage, cauliflower, broccoli, turnip, radish, spinach, asparagus, onion, pepper, celery, squash, pumpkin, cucumber, strawberry, grape, raspberry, blackberry, pineapple, avocado, mango, banana, soybean, tomato, sorghum, sugarcane, and algae.

### Claim 11

A method for producing terpenoids using a transgenic plant comprising the steps of:
providing a transgenic plant comprising a first heterologous nucleic acid encoding a polypeptide having HMGR activity and a second heterologous nucleic acid encoding a polypeptide having MPD or PMK activity such that the first and second heterologous nucleic acids are overexpressed in the transgenic plant as compared to a corresponding wild-type plant; and
growing the transgenic plant under desired conditions such that one or more terpenoids of interest are produced.

### Claim 12 (depends on 11)

The method of claim 11, further comprising the step of isolating one or more terpenoids of interest from the transgenic plant after growth.

### Claim 13 (depends on 11)

The method of claim 11, wherein the transgenic plant is grown in the presence of labeled carbon dioxide, water, or a combination thereof.

### Claim 14 (depends on 11)

The method of claim 11, wherein the step of providing a transgenic plant further comprises the steps of:
transforming plant cells with Agrobacterium containing a vector carrying the first heterologous nucleic acid encoding a polypeptide having HMGR activity in a context that allows for the overexpression of the first heterologous nucleic acid in a transgenic plant;
transforming the plant cells with a gene containing a vector carrying the second heterologous nucleic acid encoding a polypeptide having PMK activity in a context that allows for the overexpression of the second heterologous nucleic acid in a transgenic plant;
selecting transformants that overexpress both the first and second heterologous nucleic acids; and
growing the transformants into a transgenic plant.

### Claim 15 (depends on 11)

The method of claim 11, further comprising the step of transforming plant cells with a nucleic acid sequence operably linked to one or more regulatory elements for directing expression of the nucleic acid sequence in the plant cells, the nucleic acid sequence encoding a synthase for catalyzing the formation an exogenous terpenoid product of interest; and
wherein the step of selecting transformants that contain and overexpress both the first and second heterologous nucleic acids further comprises selecting transformants that express at least a portion of the exogenous terpenoid product of interest.

### Claim 16 (depends on 11)

The method of claim 11, wherein the transgenic plant produces one or more terpenoids of interest at or over a 20-fold increase relative to terpenoid production of each terpenoid of interest in a corresponding wild-type plant.

### Claim 17

A method for producing a transgenic plant cell culture comprising the steps of:
obtaining transgenic plant cells by co-transforming plant cells with:
a first heterologous nucleic acid encoding a polypeptide having HMGR activity, and
a second heterologous nucleic acid encoding a polypeptide having PMK activity;
culturing a plurality of the transgenic plant cells; and
selecting and isolating from the plurality of transgenic plant cells a subset of transgenic plant cells where expression of the first and second nucleic acids are amplified as compared to wild-type resulting in a transgenic plant cell culture.

### Claim 18 (depends on 17)

The method of claim 17, wherein:
the step of obtaining transgenic plant cells further comprises co-transforming the plant cells with a third nucleic acid comprising a sequence encoding a synthase for catalyzing the formation an exogenous terpenoid product of interest;
the method further comprises the step of cultivating the transgenic plant cells so that at least a portion of the exogenous terpenoid product of interest encoded by the third nucleic acid is expressed by the transgenic cells; and
the subset of transgenic plant cells in the selecting and isolating step further comprises transgenic plant cells expressing at least a portion of the exogenous terpenoid product of interest.

### Claim 19 (depends on 17)

The method of claim 17, wherein the transgenic plant cell culture produces β-caryophyllene and 5-epi-aristolochene at or near a 17-fold and a 63-fold increase, respectively, relative to β-caryophyllene and 5-epi-aristolochene emission in a corresponding wild-type plant cell culture.

### Claim 20 (depends on 17)

The method of claim 17, further comprising the step of growing transgenic plant tissue from the subset of transgenic plant cells.
